Owkin
Level 22: Biology, Chemistry & Drug Discovery
Science · Level 22
In short
Owkin is an AI tool in the Biology & Medicine category from Owkin France SAS in Paris, France. The pricing model is paid. It is with an English interface that handles German content.
What is Owkin?
Owkin is an AI-powered biotechnology company focused on medical research and drug discovery. The platform utilizes federated learning to securely analyze data from various clinical sources without requiring sensitive patient data to leave their original environments. This approach enables collaboration between research institutions while maintaining the highest standards of data privacy and sovereignty.
The company's technological architecture is built on advanced machine learning algorithms designed to identify complex biological patterns within large-scale datasets. It integrates multimodal data, such as genomic information or pathology slides, to derive more precise medical insights. The primary objective is to accelerate the development of new therapies and improve patient care through highly personalized medical strategies.
In practice, Owkin assists pharmaceutical companies and academic institutions in designing more efficient clinical trials and identifying novel therapeutic targets. The company collaborates closely with leading university hospitals globally to enhance the quality of medical research consistently. By combining bioscience expertise with cutting-edge computer science, the company sets new benchmarks in data-driven healthcare research.
Core features & strengths
- Federated Learning Technology — Enables the training of AI models across distributed locations without the need for data transfer. This preserves hospital data sovereignty and adheres to stringent security protocols.
- Multimodal Data Analysis — The platform can process various data types, such as medical images, molecular profiles, and clinical reports, simultaneously. This provides a comprehensive overview of disease progression and biological correlations.
- Precision Medicine Platform — Owkin offers specialized tools for biomarker discovery, which assists in patient selection for clinical trials. This increases success rates and facilitates the development of targeted therapies.
Who is this tool for?
The tool is primarily aimed at pharmaceutical companies, biotech organizations, and academic research hospitals. It is ideal for teams operating in the fields of drug development or translational medicine.
Typical use case
A pharmaceutical company aims to test the efficacy of a new oncology treatment within a specific patient population. By utilizing Owkin's federated learning platform, they access anonymized, decentralized data from specialized cancer centers. The AI identifies patterns in pathology images and genetic data that indicate a positive response to the therapy. Consequently, the company can optimize the cohort for a clinical trial, reducing research timelines and significantly increasing result validity.
What is Owkin good for?
- The tool is primarily aimed at pharmaceutical companies, biotech organizations, and academic research hospitals. It is ideal for teams operating in the fields of drug development or translational medicine.
- A pharmaceutical company aims to test the efficacy of a new oncology treatment within a specific patient population.
- Federated Learning Technology: Enables the training of AI models across distributed locations without the need for data transfer. This preserves hospital data sovereignty and adheres to stringent security protocols.
- Multimodal Data Analysis: The platform can process various data types, such as medical images, molecular profiles, and clinical reports, simultaneously. This provides a comprehensive overview of disease progression and biological correlations.
- Precision Medicine Platform: Owkin offers specialized tools for biomarker discovery, which assists in patient selection for clinical trials. This increases success rates and facilitates the development of targeted therapies.
When a different tool fits better
Owkin is not intended for small private medical practices or clinical facilities without dedicated research departments. It is not designed as a general-purpose diagnostic tool for routine clinical patient care.
Pricing & plans
Plans in detail
- Enterprise Solutionson requeston requestcustom
- Customized implementation for research networks
- Tailored AI models for drug discovery
Good to know
- No public pricing available.
- Solutions are licensed individually based on project scope and requirements.
Prices checked on 26/09/2026. Prices based on public provider information, without warranty. Euro amounts are approximations; the provider's pricing page prevails.
Supported languages
The website is primarily in English; specific content is occasionally available in other languages.
Interface = the tool's menu language, content = the language you can work in. Without guarantee — vendors keep expanding their language coverage.
Privacy & GDPR
Data flow: Data typically remains at the source institutions (hospitals) during Federated Learning; Owkin acts as the infrastructure provider.
Training on your inputs: Inputs are not used for public model training; training occurs locally on partner servers under strict confidentiality agreements.
For companies: Enterprise contracts are negotiated individually; DPAs and EU Standard Contractual Clauses are standard for medical data processing.
Practical advice: Intended for professional use in medical research only; do not input sensitive, non-anonymized patient data without appropriate authorization.
- GDPR:
- EU data protection regulation: defines how personal data may be processed and what rights you have (access, deletion, objection).
- SCC (Standard Contractual Clauses):
- EU model clauses that let a provider legally process data outside the EU.
- On-premises / local:
- The model runs on your own machine or server. Data never leaves your network — the safest option from a privacy standpoint.
- Training on user data:
- Your inputs may feed into future model versions. Confidential content could in theory resurface in other users' answers.
Privacy data checked on 05/09/2026. Editorial summary based on public provider information — not legal advice. When in doubt, check the provider's current privacy terms.
Fact sheet
| Vendor | Owkin France SAS |
|---|---|
| Headquarters | Paris, France |
| Category | Biology & Medicine |
| Pyramid level | Level 22 – Biology, Chemistry & Drug Discovery |
| Pricing model | Paid |
| Free forever option | No |
| Open Source | No |
| Entry plan | Enterprise Solutions: on request (on request) |
| German | content only, English interface |
| English | interface and content |
| Additional languages | 1 |
| Privacy classification | Unclear |
| Data processing agreement | Enterprise contracts are negotiated individually; DPAs and EU Standard Contractual Clauses are standard for medical data processing. |
Alternatives to Owkin
- AlphaFold — Open Source · HQ: London, United Kingdom · GDPR / EU
- Cradle — Paid · HQ: Amsterdam, Netherlands · GDPR / EU
- ESMFold — Open Source · HQ: Menlo Park, United States · GDPR / EU
- RoseTTAFold — Open Source · HQ: Seattle, United States · US Cloud
- Schrödinger Maestro — Paid · HQ: New York, United States · Unclear
Still unsure? The AI Tool Finder shows you alternatives.
